Article Listing - Xanthus' Xanafide sees good safety data

EC PHARMA MARKET FORECASTS TO 1996

27 April 1992

The European Community pharmaceutical market is expected to continue growing over the next five years at a rate in excess...

GOOD 1991 FOR FRANCE'S JOUVEINAL

27 April 1992

With 1991 turnover of 946 million francs ($168.8 million), French pharmaceutical comp-any Jouveinal witnessed an 8% improvement on the previous...

ACEIs & PREGNANT WOMEN

27 April 1992

US pharmacists have been asked by the Food and Drug Administration to counsel women of child bearing potential who are...

MEIJI MILK PRODS TEST-MARKETING PREGNANCY TEST

27 April 1992

Meiji Milk Products of Japan has begun test-marketing a pregnancy test which is produced by Ortho Pharmaceutical Corp of the...

FRENCH GOV'T SUPPORT FOR R-P

27 April 1992

Rhone-Poulenc is to receive French government financing worth 610 million francs ($108 million) for its biotechnology R&D program. The program...

CONTROVERSIAL ALLERGY THERAPIES

27 April 1992

A report from the UK Royal College of Physicians concludes that many of the claims made for the efficacy of...

STOCK MARKET COMMENTARY: TOKYO

27 April 1992

TOKYO: stocks were thinly traded last week, as foreign investors packed up for the Easter holiday, but the Nikkei Average...

STOCK MARKET COMMENTARY: NEW YORK

27 April 1992

NEW YORK: experienced a triple-witching hour ahead of the Easter weekend, which pushed the Dow Jones to a new high,...

Mexico Import Regulations

27 April 1992

The Mexican Ministry of Health has announced intensification of control measures to avoid the illegal entry of medi-cines from foreign...

SOLVAY PROGRESS IN HEALTH CARE

27 April 1992

Belgian chemicals and drugmaker Solvay & Cie has said that the progress made in its human health care operations has...

Showing 94161-94170 of 95368 articles

Go to beginningPreviousNextGo to end